1. Home
  2. JAGX vs BGLC Comparison

JAGX vs BGLC Comparison

Compare JAGX & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

N/A

Current Price

$0.87

Market Cap

4.9M

Sector

Health Care

ML Signal

N/A

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$1.57

Market Cap

4.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JAGX
BGLC
Founded
2013
2017
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
4.4M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
JAGX
BGLC
Price
$0.87
$1.57
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
104.5K
6.2K
Earning Date
04-07-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
82.42
45.78
EPS
N/A
N/A
Revenue
$11,511,000.00
$7,424,911.00
Revenue This Year
$61.58
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$1.07
52 Week High
$8.00
$6.10

Technical Indicators

Market Signals
Indicator
JAGX
BGLC
Relative Strength Index (RSI) 24.13 48.38
Support Level $0.60 $1.55
Resistance Level $0.99 $2.15
Average True Range (ATR) 0.09 0.08
MACD 0.03 0.04
Stochastic Oscillator 9.01 90.48

Price Performance

Historical Comparison
JAGX
BGLC

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

Share on Social Networks: